These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 26878467)
1. Two-year follow-up after bioresorbable vascular scaffold implantation in STEMI patients - Results from PRAGUE-19 study. Toušek P; Kočka V; Malý M; Kozel M; Robert P; Hajšl M; Jarkovský J; Widimský P Int J Cardiol; 2016 Apr; 209():20-1. PubMed ID: 26878467 [No Abstract] [Full Text] [Related]
2. A Polymeric Bioresorbable Vascular Scaffold Versus an Everolimus-Eluting Stent in ST-Segment Elevation Myocardial Infarction. Wernly B; Latib A; Ielasi A; Jung C J Invasive Cardiol; 2019 Sep; 31(9):E271-E272. PubMed ID: 31478894 [TBL] [Abstract][Full Text] [Related]
3. Drug-Eluting Resorbable Magnesium Scaffold Implantation in ST-Segment Elevation Myocardial Infarction: A Pilot Study. de Hemptinne Q; Picard F; Briki R; Awada A; Silance PG; Dolatabadi D; Debbas N; Unger P J Invasive Cardiol; 2018 Jun; 30(6):202-206. PubMed ID: 29656279 [TBL] [Abstract][Full Text] [Related]
4. Real life experience with bioresorbable-polymer everolimus-eluting stents. Is this an answer in search of a question? Rahban Y; Kimmelstiel C Catheter Cardiovasc Interv; 2017 Nov; 90(6):888-889. PubMed ID: 29148244 [TBL] [Abstract][Full Text] [Related]
5. Very late scaffold thrombosis of everolimus-eluting bioresorbable scaffold following implantation in STEMI after discontinuation of dual antiplatelet therapy. Yahagi K; Virmani R; Kesavamoorthy B Cardiovasc Interv Ther; 2017 Jan; 32(1):53-55. PubMed ID: 26521263 [TBL] [Abstract][Full Text] [Related]
6. Differential thrombotic prolapse burden in either bioresorbable vascular scaffolds or metallic stents implanted during acute myocardial infarction: The snowshoe effect: Insights from the maximal footprint analysis. Diletti R; van der Sijde J; Karanasos A; Fam JM; Felix C; van Mieghem NM; Regar E; Rapoza R; Zijlstra F; van Geuns RJ Int J Cardiol; 2016 Oct; 220():802-8. PubMed ID: 27394977 [TBL] [Abstract][Full Text] [Related]
7. Clinical findings after bioresorbable vascular scaffold implantation in an unrestricted cohort of patients with ST-segment elevation myocardial infarction (from the RAI registry). Moscarella E; Ielasi A; Varricchio A; De Angelis MC; Loi B; Tarantini G; Calabrò P; Cortese B; Mazzarotto P; Gabrielli G; Pisano F; Facchin M; Misuraca L; Lucci V; Gistri R; Tumminello G; Moretti L; Colombo A; Durante A; Fineschi M; Piraino D; Ferrario M; Coscarelli S; Nicolino A; Tespili M; Corrado D; Steffenino G Int J Cardiol; 2018 May; 258():50-54. PubMed ID: 29429635 [TBL] [Abstract][Full Text] [Related]
8. Subacute thrombosis after primary percutaneous coronary intervention with bioresorbable vascular scaffold implantation. Tomaniak M; Kochman J; Kołtowski Ł; Pietrasik A; Rdzanek A Kardiol Pol; 2015; 73(4):300. PubMed ID: 25892264 [No Abstract] [Full Text] [Related]
9. Optical coherence tomography in STEMI with bioresorbable scaffold: possible cause of coronary flow impairment? A sub-study from the Prague 19 trial. Loffi M; Tousek P; Budesinsky T; Lisa L; Santangelo A; Widimsky P; Kocka V Heart Vessels; 2018 Nov; 33(11):1282-1287. PubMed ID: 29777297 [TBL] [Abstract][Full Text] [Related]
10. ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison. Brugaletta S; Gori T; Low AF; Tousek P; Pinar E; Gomez-Lara J; Ortega-Paz L; Schulz E; Chan MY; Kocka V; Hurtado J; Gomez-Hospital JA; Giacchi G; Münzel T; Lee CH; Cequier A; Valdés M; Widimsky P; Serruys PW; Sabaté M Int J Cardiol; 2016 Jul; 214():483-4. PubMed ID: 27096965 [No Abstract] [Full Text] [Related]
11. Short-term outcomes following "full-plastic jacket" everolimus-eluting bioresorbable scaffold implantation. Kawamoto H; Panoulas VF; Sato K; Miyazaki T; Naganuma T; Sticchi A; Latib A; Colombo A Int J Cardiol; 2014 Dec; 177(2):607-9. PubMed ID: 25443250 [No Abstract] [Full Text] [Related]
12. Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update. Toušek P; Kočka V; Malý M; Kozel M; Petr R; Hajsl M; Jarkovský J; Lisa L; Buděšínský T; Widimský P EuroIntervention; 2016 May; 12(1):23-9. PubMed ID: 27173858 [TBL] [Abstract][Full Text] [Related]
13. 1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries. Tamburino C; Capranzano P; Gori T; Latib A; Lesiak M; Nef H; Caramanno G; Naber C; Mehilli J; Di Mario C; Sabaté M; Münzel T; Colombo A; Araszkiewicz A; Wiebe J; Geraci S; Jensen C; Mattesini A; Brugaletta S; Capodanno D JACC Cardiovasc Interv; 2016 Mar; 9(5):440-9. PubMed ID: 26875648 [TBL] [Abstract][Full Text] [Related]
14. Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial). Katagiri Y; Onuma Y; Asano T; Iñiguez A; Jensen LO; Cequier À; Hofma SH; Christiansen EH; Suttorp M; Brugaletta S; Räber L; Sabaté M; Windecker S; Serruys PW EuroIntervention; 2018 Dec; 14(11):e1224-e1226. PubMed ID: 30398967 [No Abstract] [Full Text] [Related]
16. Clinical Comparison With Short-Term Follow-Up of Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Stent in Primary Percutaneous Coronary Interventions. Cortese B; Ielasi A; Romagnoli E; Varricchio A; Cuculo A; Loi B; Pisano F; Corrado D; Sesana M; La Vecchia L; Summaria F; Tespili M; Silva Orrego P; Tognoni G; Steffenino G Am J Cardiol; 2015 Sep; 116(5):705-10. PubMed ID: 26100584 [TBL] [Abstract][Full Text] [Related]
17. Three-year results of ST-segment elevation myocardial infarction patients treated with a prespecified bioresorbable vascular scaffold implantation strategy: bVS STEMI STRATEGY-IT long-term. Moscarella E; Campo G; Leoncini M; Geraci S; Nicolini E; Cortese B; Loi B; Guiducci V; Saccà S; Varricchio A; Vicinelli P; De Candia G; Silvestro A; Calabrò P; Brugaletta S; Latib A; Tespili M; Ielasi A J Cardiovasc Med (Hagerstown); 2022 Apr; 23(4):278-280. PubMed ID: 35287160 [No Abstract] [Full Text] [Related]
18. Bioresorbable Vascular Scaffold Implantation: To Whom and How? Sabaté M JACC Cardiovasc Interv; 2017 Sep; 10(18):1865-1866. PubMed ID: 28935078 [No Abstract] [Full Text] [Related]
19. Bioresorbable scaffold implantation in STEMI patients: 5 years imaging subanalysis of PRAGUE-19 study. Kočka V; Toušek P; Kozel M; Buono A; Hajšl M; Lisa L; Buděšínský T; Malý M; Widimský P J Transl Med; 2020 Jan; 18(1):33. PubMed ID: 32000796 [TBL] [Abstract][Full Text] [Related]
20. One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: The PRAGUE-19 Study. Widimsky P; Petr R; Tousek P; Maly M; Linkova H; Vrana J; Hajsl M; Budesinsky T; Lisa L; Kocka V Circ Cardiovasc Interv; 2015 Dec; 8(12):e002933. PubMed ID: 26628591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]